organization · Reporting owner
Medpace Investors, LLC
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medpace Holdings, Inc.MEDP · Entity 3327 | 10% owner | March 06, 2024 | March 08, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medpace Holdings, Inc.
Report date March 06, 2024 · Filed March 08, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,733,019 |
Ending reported balance
After 2024-03-08 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2024-03-06 · Sale · Disposed 100,000 · Balance 4,833,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 2 · 2024-03-07 · Sale · Disposed 75,000 · Balance 4,758,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. Row 3 · 2024-03-08 · Sale · Disposed 25,000 · Balance 4,733,019 F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period. F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
F2: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.36 to $419.42. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F3: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $406.33 to $415.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
F4: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $402.90 to $414.195. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 18, 2020 Filed Dec 19, 2020 01:49 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 216,048 | $141.85 | $30,646,408.80 |
DisclosureSEC source: 0000899243-20-034560 · doc4.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,555,807 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $140.00 to $150.57. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 21:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 14,000 | $130.86 | $1,832,040.00 |
DisclosureSEC source: 0001567619-20-020608 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,771,855 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020, as amended on August 27, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020, as amended on August 27, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $130.00 to $131.37. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,592 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-20-017664 · doc1.xml · derivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,305 Underlying: Common Stock · 2,592 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,851 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-017664 · doc1.xml · derivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,118 Underlying: Common Stock · 1,851 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 2,592 | $16.20 | $41,990.40 |
DisclosureSEC source: 0001567619-20-017664 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,785,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 05, 2020 Filed Oct 7, 2020 20:33 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 1,851 | $14.41 | $26,672.91 |
DisclosureSEC source: 0001567619-20-017664 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,783,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | OtherCommon Stock | 9,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-016321 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,781,412 F1 · kind: Represents distributions of MEDP shares in-kind to the holders of the Reporting Person's Incentive Units. F1 · shares: Represents distributions of MEDP shares in-kind to the holders of the Reporting Person's Incentive Units. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,034 | $121.94 | $248,025.96 |
DisclosureSEC source: 0001567619-20-016142 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,790,766 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $121.02 to $123.07. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 26, 2020 Filed Aug 28, 2020 20:11 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,889 | $123.53 | $1,715,708.17 |
DisclosureSEC source: 0001567619-20-016142 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,792,800 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $122.57 to $124.58. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 25, 2020 Filed Aug 26, 2020 20:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 11,597 | $123.23 | $1,429,098.31 |
DisclosureSEC source: 0001567619-20-016007 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,806,689 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $120.53 to $124.41. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 24, 2020 Filed Aug 26, 2020 20:36 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,903 | $123.36 | $2,331,874.08 |
DisclosureSEC source: 0001567619-20-016007 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,818,286 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $122.23 to $126.46. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 21, 2020 Filed Aug 24, 2020 20:05 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 24,304 | $124.37 | $3,022,688.48 |
DisclosureSEC source: 0001567619-20-015895 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,837,189 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $123.08 to $126.09. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:05 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 18,813 | $125.83 | $2,367,239.79 |
DisclosureSEC source: 0001567619-20-015895 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,861,493 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $125.15 to $127.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 21,614 | $127.63 | $2,758,594.82 |
DisclosureSEC source: 0001567619-20-015812 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,880,306 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $125.965 to $128.89. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,589 | $127.26 | $2,111,116.14 |
DisclosureSEC source: 0001567619-20-015812 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,901,920 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $126.55 to $128.57. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 17, 2020 Filed Aug 18, 2020 20:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,485 | $128.18 | $2,113,047.30 |
DisclosureSEC source: 0001567619-20-015705 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,918,509 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $126.925 to $128.97. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 20:46 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,857 | $127.07 | $2,142,018.99 |
DisclosureSEC source: 0001567619-20-015705 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,934,994 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $126.17 to $128.64. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 13, 2020 Filed Aug 14, 2020 20:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 16,671 | $127.87 | $2,131,720.77 |
DisclosureSEC source: 0001567619-20-015527 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,951,851 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $126.565 to $129.03. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 20:55 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 21,916 | $127.21 | $2,787,934.36 |
DisclosureSEC source: 0001567619-20-015527 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,968,522 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $124.06 to $128.05. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 11, 2020 Filed Aug 12, 2020 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 38,642 | $125.30 | $4,841,842.60 |
DisclosureSEC source: 0001567619-20-014915 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,990,438 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $122.30 to $127.205. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 10, 2020 Filed Aug 12, 2020 20:22 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 48,148 | $120.79 | $5,815,796.92 |
DisclosureSEC source: 0001567619-20-014915 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,029,080 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $117.345 to $122.90. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 20:09 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 19,942 | $123.63 | $2,465,429.46 |
DisclosureSEC source: 0001567619-20-014631 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,077,228 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $121.485 to $124.925. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 20:09 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,033 | $122.43 | $1,840,490.19 |
DisclosureSEC source: 0001567619-20-014631 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,097,170 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $121.47 to $126.09. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 13,179 | $125.04 | $1,647,902.16 |
DisclosureSEC source: 0001567619-20-014433 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,112,203 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $123.48 to $125.905. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 04, 2020 Filed Aug 6, 2020 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 45,488 | $124.43 | $5,660,071.84 |
DisclosureSEC source: 0001567619-20-014433 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,125,382 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $123.12 to $126.605. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| August 03, 2020 Filed Aug 4, 2020 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 27,005 | $124.13 | $3,352,130.65 |
DisclosureSEC source: 0001567619-20-014145 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,170,870 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $120.485 to $125.76. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 20:13 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 39,622 | $118.17 | $4,682,131.74 |
DisclosureSEC source: 0001567619-20-014145 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,197,875 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $116.665 to $119.97. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 30, 2020 Filed Jul 31, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 42,955 | $120.79 | $5,188,534.45 |
DisclosureSEC source: 0001567619-20-013982 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,237,497 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $118.495 to $124.015. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 29, 2020 Filed Jul 31, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 47,106 | $123.99 | $5,840,672.94 |
DisclosureSEC source: 0001567619-20-013982 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,280,452 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $120.925 to $125.405. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 28, 2020 Filed Jul 29, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 214,499 | $127.23 | $27,290,707.77 |
DisclosureSEC source: 0001567619-20-013884 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,327,558 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $116.765 to $143.965. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 27, 2020 Filed Jul 29, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 29,019 | $110.43 | $3,204,568.17 |
DisclosureSEC source: 0001567619-20-013884 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,542,057 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $106.69 to $112.55. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 24, 2020 Filed Jul 27, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 34,380 | $106.13 | $3,648,749.40 |
DisclosureSEC source: 0001567619-20-013761 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,571,076 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $105.41 to $110.04. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 23, 2020 Filed Jul 27, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 31,743 | $111.83 | $3,549,819.69 |
DisclosureSEC source: 0001567619-20-013761 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,605,456 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $109.82 to $114.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 22, 2020 Filed Jul 23, 2020 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 35,878 | $109.99 | $3,946,221.22 |
DisclosureSEC source: 0001567619-20-013636 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,637,199 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $106.89 to $111.26. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 21, 2020 Filed Jul 23, 2020 20:20 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 28,090 | $106.78 | $2,999,450.20 |
DisclosureSEC source: 0001567619-20-013636 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,673,077 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $105.32 to $107.74. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 20, 2020 Filed Jul 21, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 17,735 | $105.47 | $1,870,510.45 |
DisclosureSEC source: 0001567619-20-013529 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,701,167 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $104.385 to $106.345. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 17, 2020 Filed Jul 21, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 19,309 | $105.32 | $2,033,623.88 |
DisclosureSEC source: 0001567619-20-013529 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,718,902 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $103.43 to $106.14. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 15,273 | $103.70 | $1,583,810.10 |
DisclosureSEC source: 0001567619-20-013424 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,738,211 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $103.16 to $105. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 20:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 28,700 | $104.90 | $3,010,630.00 |
DisclosureSEC source: 0001567619-20-013424 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,753,484 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $101.48 to $106.305. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 13, 2020 Filed Jul 13, 2020 20:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 6,127 | $100.50 | $615,763.50 |
DisclosureSEC source: 0001567619-20-013220 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,782,184 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F3 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $100.00 to $101.215. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| July 09, 2020 Filed Jul 13, 2020 20:56 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | SaleCommon Stock | 2,455 | $100.15 | $245,868.25 |
DisclosureSEC source: 0001567619-20-013220 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,788,311 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2020. F2 · price: The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $100.00 to $100.56. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,518 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0000899243-20-012419 · doc4.xml · derivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,969 Underlying: Common Stock · 3,518 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| May 06, 2020 Filed May 8, 2020 20:54 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 3,518 | $14.41 | $50,694.38 |
DisclosureSEC source: 0000899243-20-012419 · doc4.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,790,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,962 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-20-002092 · doc1.xml · derivative · entry 6 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,897 Underlying: Common Stock · 2,962 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,888 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-002092 · doc1.xml · derivative · entry 5 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,925 Underlying: Common Stock · 8,888 shares Expires 2021-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 14,814 | $0.00 Strike: $14.41 | $0.00 |
DisclosureSEC source: 0001567619-20-002092 · doc1.xml · derivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,487 Underlying: Common Stock · 14,814 shares Expires 2021-06-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 2,962 | $16.20 | $47,984.40 |
DisclosureSEC source: 0001567619-20-002092 · doc1.xml · nonDerivative · entry 3 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,787,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 8,888 | $14.41 | $128,076.08 |
DisclosureSEC source: 0001567619-20-002092 · doc1.xml · nonDerivative · entry 2 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,784,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 21:12 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionCommon Stock | 14,814 | $14.41 | $213,469.74 |
DisclosureSEC source: 0001567619-20-002092 · doc1.xml · nonDerivative · entry 1 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,775,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:15 UTC | Medpace Holdings, Inc. MEDP · Entity 3327 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 555 | $0.00 Strike: $16.20 | $0.00 |
DisclosureSEC source: 0001567619-19-021861 · doc1.xml · derivative · entry 4 Medpace Investors, LLC · CIK 0001524599 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,859 Underlying: Common Stock · 555 shares Expires 2022-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock options subject to this exercise are fully vested and exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.